Evidence map›Paper›PMID 32818550›Full record

ReviewCancer letters2020

Hypoxia, hypoxia-inducible gene 2 (HIG2)/HILPDA, and intracellular lipolysis in cancer.

Davide Povero, Scott M Johnson, Jun Liu

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Cancer letters, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05214885 (Novel Biomarkers of Hypoxia and Metabolism in Clear Cell Renal Cell Carcinoma), which is not on this map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05214885 recruitingnot on this mapstarted 2022, after this paper: background citation

Novel Biomarkers of Hypoxia and Metabolism in Clear Cell Renal Cell Carcinoma

TypeobservationalSponsorQianfoshan HospitalRan2022 to 2026Enrolled300ConditionsClear Cell Renal Cell CarcinomaArmsNo intervention was required for patients or control group in this study
3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Microbiology spectrum · 2025
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Davide PoveroFrom Department of Biochemistry and Molecular Biology, Rochester, MN, 55905, USA; Division of Endocrinology, Rochester, MN, 55905, USA.
Scott M JohnsonFrom Department of Biochemistry and Molecular Biology, Rochester, MN, 55905, USA; Mayo Clinic College of Medicine & Science, Rochester, MN, 55905, USA; Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN, 55905, USA.
Jun LiuFrom Department of Biochemistry and Molecular Biology, Rochester, MN, 55905, USA; Division of Endocrinology, Rochester, MN, 55905, USA. Electronic address: liu.jun@mayo.edu.
University of Minnesota Rochester · US

Funding

Mayo Clinic Center for Clinical and Translational Science (CCaTS UL1 Supplement - Dr. Timothy Curry)UL1TR002377 · NCATS · MAYO CLINIC ROCHESTER · PI VESNA D GAROVIC · 2017 to 2026
$78.4M
DIABETES AND METABOLISMT32DK007352 · NIDDK · MAYO CLINIC ROCHESTER · PI MICHAEL D. JENSEN · 1986 to 2026
$9.4M
Regulation of Hepatic Lipid Accumulation and Insulin ResistanceR01DK109096 · NIDDK · MAYO CLINIC ROCHESTER · PI LIU, JUN · 2016 to 2019
$1.5M
G0S2: a dual-function regulator of lipid and energy metabolismR56DK089178 · NIDDK · MAYO CLINIC ARIZONA · PI LIU, JUN · 2015 to 2015
$125k
NCATS NIH HHS UL1 TR002377NIDDK NIH HHS R01 DK109096NIDDK NIH HHS R56 DK089178NIDDK NIH HHS T32 DK007352
6 · The paper itself

Abstract

Tumor tissues are chronically exposed to hypoxia owing to aberrant vascularity. Hypoxia induces metabolic alterations in cancer, thereby promoting aggressive malignancy and metastasis. While previous efforts largely focused on adaptive responses in glucose and glutamine metabolism, recent studies have begun to yield important insight into the hypoxic regulation of lipid metabolic reprogramming in cancer. Emerging evidence points to lipid droplet (LD) accumulation as a hallmark of hypoxic cancer cells. One critical underlying mechanism involves the inhibition of adipose triglyceride lipase (ATGL)-mediated intracellular lipolysis by a small protein encoded by hypoxia-inducible gene 2 (HIG2), also known as hypoxia inducible lipid droplet associated (HILPDA). In this review we summarize and discuss recent key findings on hypoxia-dependent regulation of metabolic adaptations especially lipolysis in cancer. We also pose several questions and hypotheses pertaining to the metabolic impact of lipolytic regulation in cancer under hypoxia and during hypoxia-reoxygenation transition.

Indexed as

AcyltransferasesDown-RegulationGene Expression Regulation, NeoplasticHumansLipaseLipid DropletsLipolysisNeoplasm ProteinsNeoplasmsTumor HypoxiaAcyltransferasesHILPDA protein, humanLipaseNeoplasm ProteinsPNPLA2 protein, humanATGLFatty acidHIFHIG2HILPDAHypoxiaHypoxia-inducible factorHypoxia inducible gene 2Lipid dropletLipolysisOxygen

Identifiers

PMID32818550
PMCPMC11218043
OpenAlexW3072976483

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.